静脉与毛细血管血常规生化项目一致性:采集部位与样本基质的影响
单中心配对临床研究纳入480名成人,采集960份毛细血管样本(指尖采血针与上臂微针装置)及匹配静脉样本,评估三种毛细血管基质中18项常规生化项目。应用HIL切点后16/18项临床可比,钾和氯互换性有限;多数项目一致性良好,部分项目存在采集部位相关小偏移但仍在TEa内。
要点
- 应用HIL切点后,18项常规生化中16项毛细血管与静脉结果临床可比。
- 钾和氯的互换性有限,需进一步评估装置与采集部位效应。
- 指尖采血血量更大、采集失败更少,但溶血率更高。
核心结论
- 在常规接受标准下,毛细血管检测对多数临床生化项目表现可接受。
- 钾和氯受装置与采集部位相关效应影响,互换性有限。
研究设计与样本
- 单中心配对临床研究,纳入480名成人,采集960份毛细血管样本(指尖采血针与上臂微针装置)及匹配静脉样本。
- 评估三种毛细血管基质(血清、肝素血浆、K2EDTA血浆),18项常规生化项目在单一整合平台上检测。
- 方法可比性遵循CLSI EP09和EP35,临床相关性采用EFLM生物学变异数据库的理想TEa评估。
主要发现
- 应用指定HIL切点后,16/18项分析物毛细血管与静脉结果临床可比。
- 多数检测项目在不同基质和采集部位间一致性良好。
- 部分分析物(白蛋白、肌酐、甘油三酯、CRP、NT-proBNP、HDL胆固醇)存在小的采集部位依赖偏移,但仍在TEa内。
- 指尖采集比TAP Micro Select采血量更大、采集失败更少,但溶血更高。
关键数值与推荐
- 毛细血管与静脉结果在16/18项分析物中临床可比(应用指定HIL切点)。
- 钾和氯显示有限互换性。
- 部分分析物采集部位依赖偏移仍在EFLM理想TEa内。
临床怎么用
- 在常规接受标准下,毛细血管检测可用于多数临床生化项目。
- 钾和氯结果解读需谨慎,考虑装置和采集部位影响。
- 指尖采集血量更大、失败更少,但需注意溶血。
局限性
- 单中心研究。
- 钾和氯的装置与采集部位效应需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Capillary blood sampling enables minimally invasive testing and decentralized workflows, but interchangeability with venous specimens may depend on collection site, device, and matrix. METHODS: We conducted a single-center, paired clinical study of 480 adults yielding 960 capillary specimens (fingertip lancet and upper-arm microneedle device) together with matched venous samples. We evaluated three capillary matrices (serum, heparin plasma, K2EDTA plasma). Routine analytes (n=18) spanning lipid, kidney, thyroid, and cardiac panels were measured on a single integrated platform (Cobas® Pro c503/e801/ISE). HIL (hemolysis, icterus, lipemia) indices governed sample acceptance. Method comparability followed Clinical and Laboratory Standards Institute (CLSI) EP09 and EP35 and clinical relevance was assessed using the desirable total allowable error (TEa) specifications from the EFLM Biological Variation Database. RESULTS: Capillary and venous results were clinically comparable for 16/18 analytes when specified HIL cutoffs were applied, although potassium and chloride showed limited interchangeability. Agreement was strong for most measurands across matrices and sites; small, collection site-dependent offsets were observed for selected analytes (e.g., albumin [method-dependent], creatinine [method-dependent], triglycerides, C-reactive protein (CRP), N-terminal pro B-type natriuretic peptide (NT-proBNP), HDL-cholesterol) yet remained within TEa. Fingertip collections yielded larger volumes and fewer collection failures than TAP Micro Select but showed higher hemolysis. CONCLUSIONS: Under routine acceptance criteria, capillary testing demonstrates acceptable performance for most clinical chemistry analytes across matrices. For potassium and chloride, device- and collection-site-related effects warrant further evaluation. This protocol integrates collection-site and matrix assessment and constitutes one of the largest evaluations of venous-capillary interchangeability and supports adoption of decentralized testing workflows.
引用
- Deza S, Fernández-Montero A, Calleja S, et al. Venous-capillary blood agreement for routine chemistry analytes: effects of collection site and sample matrix. Clin Chem Lab Med. 2026. PMID: 42446434. doi:10.1515/cclm-2026-0671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。